Clinical Trial Update: Safety and Immunogenicity of a Mycobacterium Tuberculosis Vaccine MTBVAC in Healthy Indian Adults and Adolescents (BBV169/2024) [Phase 2]

View source ↗

Summary

Phase 2 trial assessing safety and immunogenicity of the MTBVAC tuberculosis vaccine in healthy Indian adults and adolescents; the study is currently recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• MTBVAC

Snippet

Sponsor: Bharat Biotech International Limited | Conditions: Tuberculosis (TB) | Phase 2 | Status: RECRUITING